UP!
| 2013-09-18 | Downgrade | WBB Securities | Buy to Hold | $1.50 |
| 2013-03-19 | Downgrade | MLV & Co | Hold to Sell | $0.50 |
| 2013-02-25 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2013-02-25 | Downgrade | Robert W. Baird | Outperform to Neutral | $30 to $4 |
| 2013-02-25 | Downgrade | MLV & Co | Buy to Hold | |
| 2012-05-21 | Reiterated | MLV & Co | Buy | $12 to $21 |
| 2012-05-08 | Downgrade | WBB Securities | Strong Buy to Buy | $9 to $17 |
| 2011-09-27 | Upgrade | WBB Securities | Buy to Strong Buy | $8 |
| 2011-03-11 | Upgrade | Auriga U.S.A | Hold to Buy | $5 to $10 |
| 2010-11-23 | Upgrade | MLV Capital | Hold to Buy | $12 |
| 2010-11-22 | Initiated | WBB Securities | Buy | $8 |
| 2010-10-11 | Reiterated | Auriga U.S.A | Hold | $9 to $5 |
| 2010-10-04 | Reiterated | Argus | Buy | $30 to $15 |
| 2010-06-21 | Downgrade | Auriga U.S.A | Buy to Hold | $36 to $9 |
| 2010-04-16 | Initiated | Auriga U.S.A | Buy | $36 |
| 2010-03-12 | Initiated | Piper Jaffray | Overweight | |
| 2009-10-06 | Upgrade | Argus | Hold to Buy | $30 |
| 2008-09-24 | Initiated | Stanford Research | Buy | $29 |
| 2008-07-30 | Downgrade | UBS | Buy to Neutral | |
| 2008-07-02 | Initiated | Robert W. Baird | Outperform | $25 |
| 1970-01-01 |
| 2013-09-18 | Downgrade | WBB Securities | Buy to Hold | $1.50 |
| 2013-03-19 | Downgrade | MLV & Co | Hold to Sell | $0.50 |
| 2013-02-25 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2013-02-25 | Downgrade | Robert W. Baird | Outperform to Neutral | $30 to $4 |
| 2013-02-25 | Downgrade | MLV & Co | Buy to Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AFFY 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| CREDIT SUISSE AG/ | 4.73% (1774407) | AFFY / PTCT / STRI / WD / |
| Orwin John A President and COO | 0.20% (76666) | AFFY / ARRY / RLYP / SGEN / |
| Morris Arlene CEO | 0.20% (75000) | AFFY / BIOD / MNOV / PTN / VIVE / |
| Cleveland Paul B EVP, Corp. Development and CFO | 0.08% (30000) | AAVL / AFFY / ALDR / CLDN / SGMO / |
| Duliege Anne-Marie Chief Medical Officer | 0.08% (28125) | AFFY / CCXI / RIGL / |
| Venteicher Robert SVP, Technical Operations | 0.07% (24994) | AFFY / |
| CROSS HERB VP, Fin. & Chief Acct. Officer | 0.06% (21370) | AFFY / KBIO / PDLI / |
| Knapp Jeffrey H Chief Commercial Officer | 0.05% (18125) | ADMS / AFFY / |
UM